Systematic Financial Management LP Exelixis, Inc. Transaction History

Systematic Financial Management LP

$3.78 Billion
Q3 2024

A detailed history of Systematic Financial Management LP transactions in Exelixis, Inc. stock. As of the latest transaction made, Systematic Financial Management LP holds 1,168,391 shares of EXEL stock, worth $41.6 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares

1,168,391

Previous 1,090,792 7.11%

Holding current value

$41.6 Million

Previous $24.5 Million 23.7%

% of portfolio

0.8%

Previous 0.77%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$21.96 - $27.6 $1.7 Million - $2.14 Million	77,599 Added 7.11%	1,168,391 $30.3 Million
Q2 2024 Aug 15, 2024	SELL	$20.34 - $23.73 $823,139 - $960,329	-40,469 Reduced 3.58%	1,090,792 $24.5 Million
Q1 2024 May 14, 2024	SELL	$20.17 - $23.93 $81,688 - $96,916	-4,050 Reduced 0.36%	1,131,261 $26.8 Million
Q4 2023 Feb 14, 2024	SELL	$19.25 - $24.13 $701,412 - $879,224	-36,437 Reduced 3.11%	1,135,311 $27.2 Million
Q2 2023 Aug 14, 2023	SELL	$18.17 - $20.48 $798,698 - $900,239	-43,957 Reduced 3.62%	1,171,748 $22.4 Million
Q1 2023 May 12, 2023	BUY	$16.3 - $19.41 $73,659 - $87,713	4,519 Added 0.37%	1,215,705 $23.6 Million
Q4 2022 Feb 15, 2023	BUY	$14.96 - $17.39 $436,637 - $507,561	29,187 Added 2.47%	1,211,186 $19.4 Million
Q3 2022 Nov 14, 2022	SELL	$15.68 - $22.27 $108,160 - $153,618	-6,898 Reduced 0.58%	1,181,999 $18.5 Million
Q2 2022 Aug 15, 2022	BUY	$17.44 - $23.16 $628,084 - $834,084	36,014 Added 3.12%	1,188,897 $24.8 Million
Q1 2022 May 11, 2022	BUY	$17.03 - $22.67 $1.01 Million - $1.34 Million	59,087 Added 5.4%	1,152,883 $26.1 Million
Q4 2021 Feb 14, 2022	SELL	$15.84 - $21.88 $362,039 - $500,089	-22,856 Reduced 2.05%	1,093,796 $20 Million
Q3 2021 Nov 12, 2021	BUY	$16.3 - $21.14 $1.18 Million - $1.53 Million	72,326 Added 6.93%	1,116,652 $23.6 Million
Q2 2021 Aug 12, 2021	BUY	$17.95 - $25.56 $4.21 Million - $5.99 Million	234,467 Added 28.95%	1,044,326 $19 Million
Q1 2021 May 10, 2021	BUY	$20.53 - $25.22 $3.25 Million - $3.99 Million	158,392 Added 24.31%	809,859 $18.3 Million
Q4 2020 Feb 12, 2021	BUY	$18.39 - $24.8 $3.26 Million - $4.4 Million	177,383 Added 37.42%	651,467 $13.1 Million
Q3 2020 Nov 12, 2020	BUY	$20.67 - $26.94 $1.7 Million - $2.21 Million	82,043 Added 20.93%	474,084 $11.6 Million
Q2 2020 Aug 13, 2020	BUY	$16.46 - $27.42 $6.45 Million - $10.7 Million	392,041 New	392,041 $9.31 Million

Others Institutions Holding EXEL

# of Institutions

501

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Systematic Financial Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Systematic Financial Management LP with notifications on news.

Account

Systematic Financial Management LP Exelixis, Inc. Transaction History